Production (Stage)
Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -14.66% | 5.84% | 18.75% | 15.45% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -14.66% | 5.84% | 18.75% | 15.45% | |
| Cost of Revenue | -17.42% | 5.68% | 19.49% | 19.44% | |
| Gross Profit | -7.39% | 6.18% | 17.12% | 6.12% | |
| SG&A Expenses | 64.59% | 4.96% | 19.32% | -0.12% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | 1,389.27% | 68.99% | -101.68% | 0.77% | |
| Total Operating Expenses | -13.55% | 5.93% | 18.86% | 14.16% | |
| Operating Income | -35.30% | 4.09% | 16.80% | 46.44% | |
| Income Before Tax | -60.47% | -1.11% | -1.29% | 376.72% | |
| Income Tax Expenses | 129.59% | 150.24% | 41.66% | 152.49% | |
| Earnings from Continuing Operations | -242.21% | -24.18% | -24.66% | 3,064.05% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -242.21% | -24.18% | -24.66% | 3,064.05% | |
| EBIT | -35.30% | 4.09% | 16.80% | 46.44% | |
| EBITDA | -55.70% | 11.41% | 11.99% | -10.00% | |
| EPS Basic | -241.98% | -23.81% | -25.23% | 2,600.00% | |
| Normalized Basic EPS | -55.88% | -1.10% | 0.00% | 385.71% | |
| EPS Diluted | -241.98% | -23.81% | -25.23% | 2,600.00% | |
| Normalized Diluted EPS | -55.88% | -1.10% | 0.00% | 385.71% | |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |